HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 16 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,392,000 | +1514.5% | 809,368 | +1093.1% | 0.02% | +2000.0% |
| Q4 2018 | $1,325,000 | -38.7% | 67,836 | -38.6% | 0.00% | -50.0% |
| Q3 2018 | $2,162,000 | -10.8% | 110,393 | -24.6% | 0.00% | 0.0% |
| Q2 2018 | $2,424,000 | +53.1% | 146,370 | +67.3% | 0.00% | 0.0% |
| Q3 2016 | $1,583,000 | -91.9% | 87,499 | -92.6% | 0.00% | -90.5% |
| Q2 2016 | $19,457,000 | -1.1% | 1,181,369 | -0.5% | 0.02% | -4.5% |
| Q1 2016 | $19,665,000 | -25.8% | 1,186,828 | -1.3% | 0.02% | -26.7% |
| Q4 2015 | $26,490,000 | +104.0% | 1,202,425 | +83.5% | 0.03% | +100.0% |
| Q3 2015 | $12,985,000 | -13.2% | 655,168 | +52.2% | 0.02% | -6.2% |
| Q2 2015 | $14,956,000 | +13.4% | 430,535 | -15.2% | 0.02% | +6.7% |
| Q1 2015 | $13,187,000 | +15.3% | 507,761 | -42.8% | 0.02% | +15.4% |
| Q4 2014 | $11,434,000 | +7.4% | 887,011 | +2.3% | 0.01% | 0.0% |
| Q3 2014 | $10,648,000 | – | 867,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |